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ScienceDirectCutaneous healing is a highly complex process that, if altered
due to, for example, impaired vascularization, results in chronic
wounds or repaired neotissue of poor quality. Significant
progress has been achieved in promoting neotissue
vascularization during tissue repair/regeneration. In this review,
we discuss the strategies that have been explored and how
each one of them contributes to regulate vascularization in the
context of cutaneous wound healing from two different
perspectives — biomaterial-based and a cell-based
approaches. Finally, we discuss the implications of these
findings on the development of the ‘next generation’
approaches to target vascularization in wound healing
highlighting the importance of going beyond its contribution to
regulate vascularization and take into consideration the
temporal features of the healing process and of different types
of wounds.
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Introduction
Wound healing is a complex and highly regulated process,
commonly organized in phases that include (i) hemosta-
sis, (ii) inflammation, (iii) proliferation, and (iv) remodel-
ing [1]. Upon injury, intravascular platelets are activated
and secrete a series of growth factors that act as chemoat-
tractants to neutrophils and monocytes [2]. These differ-
entiate into macrophages in the inflammatory phase [3]www.sciencedirect.com releasing cytokines (vascular endothelial growth factor
(VEGF)-A, fibroblast growth factors (FGFs) and angio-
poietins (Ang)) that stimulates fibroblasts migration and
activates microvascular endothelial cells (ECs) [4].
Within a few days, angiogenic capillary sprouts invade
the fibrin/fibronectin-rich wound clot and organize into a
microvascular network due to the dynamic interaction
that occurs among ECs, angiogenic cytokines and the
extracellular matrix (ECM) environment produced by
fibroblasts (Box 1, Figure 1) [5]. However, when the
wound healing cascade is affected, as for example due
to delayed vascularization, dysfunctional healing occurs
impacting the quality of the neotissue formed. Moreover,
in chronic wounds, the angiogenic process is impaired
which, associated to a persistent inflammatory state, hin-
ders healing progression. These wounds are associated to
other co-morbidities such as diabetes and arterial and
venous insufficiencies [6], being therefore the most chal-
lenging. For example, lower limb amputation due to
diabetic foot ulcers occurs in 14%–24% of diabetes
patients; while approximately 77% of those ulcers heal
within 1 year, roughly 40% of patients have a recurrence
within 1 year after healing, almost 60% within 3 years, and
65% within 5 years [7,8]. It is then clear that chronic
wounds have a growing prevalence worldwide being a
major health problem with important social and economic
implications with an urge need for improved therapeutic
approaches.
Significant progress has been achieved in promoting
neotissue vascularization during tissue repair/regenera-
tion [9]. Whether these have considered the needs of each
cutaneous wound where a local and temporal effect must
be attained to promote not only wound closure — open
skin wounds might be life-threatening — but also the
neotisue quality — directly associated to tissue function-
ality also critical for keeping body homeostasis – should
be analyzed. In this review, the strategies that have been
explored and how each one of them contributes to regu-
late vascularization in the context of cutaneous wound
healing were analyzed from two different perspectives —
biomaterial-based and a cell-based approaches. We dis-
cuss the efforts that have been made to optimize bioma-
terials/scaffolds to have spatial, temporal or spatio-tem-
poral control of angiogenesis/vascularization at wound site
[10,11] (Figure 2). Spatial regulation can be mostly asso-
ciated to the target of local cells by presenting-specific
peptides at the biomaterials surface that then drive integ-
rin-mediated angiogenesis. On the other hand, regulation
of angiogenesis along time is intrinsically linked toCurrent Opinion in Biotechnology 2022, 73:253–262
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Box 1 Vasculogenesis versus angiogenesis
In adult skin, within the wound, neovascularization occurs through
blood vessel formation via vasculogenesis or angiogenesis (Figure 1)
[17]. Vasculogenesis — generation of new vascularization in the
absence of preexisting blood vessels — takes place when EPCs
home to the damaged site and differentiate into ECs to form primitive
vascular networks [18]. However, in the context of wound healing,
angiogenesis — formation of new blood vessels from pre-existing
vasculature [19] — is the most common vascularization process.
Sprouting angiogenesis, starts with an EC — tip cell — in an existing
vessel that degrades the original basement membrane with a highly
controlled proteolytic activity cleaving basement membrane and
interstitial proteins. As a result, EC projects protrusions through the
gap in the basement membrane into the interstitium leading a string
of ECs that are able to proliferate and create a branch, increasing in
complexity with the growth of the vascular network [18]. Although the
angiogenesis process in adult cutaneous wound healing is well-
established, the existence and the potential role of vasculogenesis
process in this healing process is controversial and not yet clear [17].angiogenic byproducts or via controlled release/delivery
of angiogenic growth factors (GFs) or respective encoding
genetic material. Regarding cell-based approaches, pre-
vascularization of cellular tissue engineered constructs
using both mature [12] and progenitor [13,14] ECs is one
of the most successful approaches in fostering vasculari-
zation at wound site. However, the clinical use those cells
is highly hampered by an insufficient number required for
therapy due to senescence and impaired capacities for
vascular repair associated to their expansion in vitro [15].
Knowing that ECs wound surroundings are key to the
process of new vessels formation [16] we discuss how theFigure 1
Angiogenesis
Vasculogenesis and angiogenesis in wound healing.
EC — endothelial cell; EPCs — endothelial progenitor cells.
Current Opinion in Biotechnology 2022, 73:253–262 angiogenic signals secreted by other skin cells, represent
an opportunity to define new strategies capable of direct-
ing wound healing angiogenesis (Figure 3). Moreover, we
discuss how adipose tissue has been contributing to
promote the neovascularization of wounds focusing on
the angiogenic secretome of ASCs and on the cellular
complexity of adipose tissue stromal vascular fraction
(SVF) highlighting its potential as an alternative to pro-
mote constructs pre-vascularization.
Biomaterial-controlled vascularization in skin
wound healing
Spatial regulation
Because of the recognition of biological cues by cell
integrins, peptide-functionalized materials have been
explored to promote adhesion of angiogenic cells, such
as ECs and EPCs, fostering angiogenesis locally at the
wound site. These cells recognize the underlying matrix
through different sets of integrins, which are known to be
involved in triggering signaling pathways related to
migration, proliferation and organization in vascular net-
works [9,20]. Early studies showed that materials
functionalized with the A13 and C16 sequence from
laminin [21] and the RGD and the heparin-binding
domain of fibrin (Fg b15–66(2)) [22] promoted higher
EC migration and improved neovessel formation in
full-thickness wounds. However, most of these peptides
have no selectivity for angiogenic cells and therefore can
mediate adhesion of other cells resulting in a competitive
environment that can be detrimental for local angiogene-
sis. This was in fact demonstrated with alginate hydrogelsVasculogenesis
Current Opinion in Biotechnology
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Biomaterial-based strategies to promote vascularization in wound healing.
EC — endothelial cell, GF — growth factor, MMP — metalloproteinase, pDNA — plasmid encoding DNA.functionalized with peptides specific for a4b1 integrin.
Materials with the REDV sequence showed superior
capability to promote selective adhesion and proliferation
of ECs in vitro and higher density of newly formed vessels
after subcutaneous implantation in rats, than the ones
with the RGD or the YIGSR peptides [23]. The impor-
tance of this specificity was recently reinforced with
hyaluronic acid hydrogels functionalized with the fibro-
nectin fragment (Fn9-10) that was designed to be specific
for a3/a5b1-integrin or avb3-integrin [24]. Matrices
with the a3/a5b1 led to the formation of non-leaky blood
vessels in opposition those with specificity for avb3
integrin, which was attributed to the higher expression
of VE-cadherin at cell–cell junctions. Interestingly, RGD
and avb3-ligand functionalized matrices led to similar
ECs sprouting and formation of disorganized structures
however, this was observed only for a much higher
concentration of RGD peptide (>500 mM) than fibronec-
tin fragments used (2 mM).www.sciencedirect.com While these approaches highlight the possibility of spa-
tially control vascularization, whether they are effective in
cutaneous wound healing is still to be demonstrated.
Moreover, the fundamental understanding of integrin-
mediated responses to peptide-functionalized biomater-
ials, including concentration, and other neighboring
ligands, and their engagement as angiogenic/vasculogenic
initiators requires further investigation.
Temporal regulation
In processes like angiogenesis and vascularization, tem-
poral ECM remodeling is crucial for vascular cell migra-
tion and cell–cell organization [9]. Therefore, biomater-
ials — ECM mimickers — that are susceptible to
hydrolytic or enzymatic degradation are intrinsically
potential regulators of temporal tissue response. It is long
known that biomaterial degradation byproducts, such as
those of fibrin [25,26] or hyaluronic acid [27], modulate
the proliferation and migration of angiogenic cells.Current Opinion in Biotechnology 2022, 73:253–262
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Cell-based strategies in skin wound healing vascularization.
ASC — adipose-derived stem cell, EC — endothelial cell, Fbs — fibroblasts, GF — growth factors, KCs — keratinocytes, SVF — stromal vascular
fraction.However, the temporal control of angiogenesis using
these materials is limited by their degradation rates
[28,29], being therefore mostly suited for addressing
angiogenesis at early wound healing stages. The combi-
nation of these materials with others that are not degraded
enzymatically has allowed to tackle this limitation. This is
the case of hyaluronic acid and gellan gum structures that
promoted the neovascularization of ischemic mice hind
limb in a material-dependent manner, consistent with the
in vitro degradation profile (up to 28 days) [27]. These
materials were also able to support significantly higher
vessel density in diabetic mice full-thickness wounds
along the whole healing timeframe [30].
While biomaterial degradation byproducts are a valid
option, temporal regulation of angiogenesis during wound
healing has been mostly associated to the biomaterial-
mediated delivery/release of biomolecules. These
approaches take advantage of the kinetics of diffusion
controlled through materials’ bulk properties (polymer
concentration, crosslinking degree, wettability), or the
degradation rate of the matrices to which biomolecules
are coupled to. Early studies showed that VEGF [31],
basic FGF (bFGF) [32] and stromal-derived factor 1
(SDF-1) [33] delivered using fibrin matrices, gelatin
sheets and decellularized dermis, respectively, enhanced
the vascularization of full-thickness mice wounds.Current Opinion in Biotechnology 2022, 73:253–262 Despite this, co-delivery of two GFs, being VEGF the
prime angiogenic factor, seems to be more effective than
their individual administration. Moreover, the use of
angiogenic factors that are known to have specific roles
at different times of the angiogenic process was consid-
ered. This was shown with a bioengineered mussel adhe-
sive protein-based gel entrapping VEGF and platelet
derived growth factor (PDGF)-containing microparticles
in a full-thickness rat wound. While 40% of VEGF was
release during one day, PDGF was release slowly over
4 days resulting in significantly higher capillary density
and overall improved neotissue quality [34]. However,
the link between the role of each one of those factors and
the observed response was not made.
An extension of the delivery window was also considered
via covalent immobilization, yet this has not been neces-
sarily linked to a higher control of the delivery/release.
Chitosan scaffolds functionalized with VEGF and bFGF
via PEG, shown to be sensitive to the action of lysozyme
releasing in vitro up to 70% of the coupled GFs, led to
enhanced vascularization of full-thickness rat wounds at
early time-points but details on the temporal effect of the
GFs were not provided [35]. Similarly, collagen function-
alized with bFGF and keratinocyte growth factor (KGF)
via EDC/NHS supported increased blood flow in a full-
thickness rat wound between days 7 and 14 [36].www.sciencedirect.com
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groups with single GFs which demonstrates an enhanced
effect of the dual system. However, the blood flow profile
along the time was similar to all the conditions which
might correlate with the sustained release profile
observed in vitro, similar for both GFs. In other approach,
collagen scaffolds to which VEGF and SDF-1a were
coupled via a collagen binding domain, also led to the
formation of a higher number of vessels in full-thickness
wounds in diabetic rats. Interestingly, the mount of ECs
recruited to the site of injury by scaffolds loaded with up
to 20 mg of VEGF was almost null while a dose-depen-
dent response was observed for SDF-1a-containing scaf-
folds. Thus, this work seems to show that SDF-1a is
responsible for ECs recruitment that are then led by
VEGF to organize and form the vessels [37]. Also, fibrin
hydrogels containing VEGF-165 and PDGF-BB coupled
via a high GFs affinity peptide (LAMA33043-3067), led to
a significantly increased frequency of proliferative cells in
full-thickness wounds in type-2 diabetic mice compared
to other treatment groups at day five. This is consistent
with an early effect of the co-delivery of those GFs that
results in an accelerated healing [38]. In this case,
neovascularization might also have been potentiated by
the synergistic effect of the fibrin byproducts although
authors do not take this into consideration.
Despite what was achieved with the delivery of GFs,
limitations that includes bolus release of proteins, short
half-life due to lack of protection from proteolytic
degradation, and the requirement of high doses to
achieve a therapeutic effect [39], which in the case
of angiogenic factors can be linked to tumor develop-
ment [40] are still a reality. Biomaterials delivering
genetic material encoding for specific angiogenic pro-
teins have been showing to foster the sustained pro-
duction of GFs by host cells. Gene-activated matrices
(GAMs) or scaffolds rely on combining non-viral vector
therapeutic genes within 3D structures that offer struc-
tural support and a matrix for new tissue deposition
[41]. Up to now, collagen/chitosan scaffolds loaded with
lipofectamine 2000/pVEGF transplanted into full-
thickness wounds in rats lead to an upregulation of
VEGF secretion that resulted in an increased number
of newly formed vessels 9 days post-implantation than
the structures with non-complexed pVEGF or with
lipofectamine/pGFP [42]. Similarly, hyaluronic acid/
dextran hydrogels containing polyethyleneimine
(PEI)/pVEGF promoted microvessels formation in
full-thickness rat burns, in a higher extent than the
hydrogel alone due to the effective secretion of VEGF
from the in situ transfected cells over 7 days [43].
Overall, independently of the strategy the challenge to
control vascularization in cutaneous wound healing still
relies on matching the exact temporal profile of delivery
that responds to its evolution.www.sciencedirect.com Spatio-temporal regulation
As discussed, biomaterial-based approaches are capable of
individually impacting neovascularization both at spatial
and temporal level. One might question if spatio-tempo-
ral strategies synergize towards this, being more success-
ful in accelerating vascularization in wound healing. Bio-
materials have been functionalized with peptides that are
recognized by angiogenic cells promoting adhesion and
act as sensitive biodegradation sites supporting, along
time and depending on the degradative milieu, cell
migration, proliferation and organization. In hyaluronic
acid-modified hydrogels, EC migration throughout the
matrices was enabled through the MMP-sensitive cross-
linker (GCRDGPQG#IWGQDRCG), and vacuole and
lumen formation were RGD dose-dependent [44]. This
organization was observed within 36 hours, while the
cell migration was assumed to lead the creation of
‘vascular guidance tunnels’ that supported branching
and sprouting after 2–3 days. In another approach, T1
(GQKCIVQTTSWSQCSKS) or C16 (CGGKAFDI-
TYVRLKF) peptides linked to in gellan gum were shown
to determine EC adhesion in a concentration-dependent
manner, while the MMP-1 cleavable peptide
(CRDGPQGIWGQDRC) allowed opening space in the
polymeric network of the hydrogel for subsequent cell
spreading [45]. Despite the modest results, it might be
argued that the in vitro concentration of MMP-1 and the
time of culture were not sufficient to further degrade the
matrix degradation allowing ECs organization.
Overall, as precise spatial and temporal regulation of
angiogenesis is necessary for enhanced wound healing
and formation of neotissue with a quality closer to the
native one, the combinatorial approach may be the best
approach to mimic regulation of angiogenesis using bio-
materials properties.
Cell-controlled vascularization in skin wound
healing
Dermal and epidermal cells signaling
While poorly representing the complexity of native tis-
sue, skin substitutes are in general effective in promoting
wound healing. Dermal and dermal-epidermal products
composed respectively by fibroblasts, and fibroblasts and
keratinocytes, can however be associated to delayed
engraftment mostly due to deficient neo-vascularization.
It is also known that both keratinocytes and fibroblasts
impact ECs, which seems to reveal that the potential of
those cells as part of dermal-epidermal skin substitutes is
not maximized. During the proliferation and remodeling
phases of the wound healing, fibroblasts secretion of
keratinocyte GF-1 (KGF-1), KGF-2 and interleukin-6
(IL-6) have a profound effect on migration, proliferation
and differentiation of keratinocytes [46,47]. In response
to these factors, keratinocytes are also prompt to secret
VEGF, which guides angiogenesis in the wound tissue
through the upregulation of nitric oxide (NO) in ECs [48].Current Opinion in Biotechnology 2022, 73:253–262
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observed after transplantation of skin substitutes contain-
ing keratinocytes genetically modified to overexpress
VEGF [49,50]. Moreover, keratinocyte-to-EC crosstalk
is known to be involved in wound angiogenesis. Impaired
EC migration and angiogenesis was observed in epider-
mis-specific a3-integrin-knockout mice due to the
reduced expression of the pro-angiogenic factor MRP3
by keratinocytes [51]. Therefore, novel signaling mecha-
nisms may prospectively be targeted in keratinocytes to
promote angiogenesis during wound-healing, particularly
at the re-epithelialization stage.
The crosstalk between keratinocytes-fibroblasts-ECs is
thought to be responsible for regulating microvascular
density within the papillary and reticular dermis [52],
being therefore also an axis of interest to target during
wound healing. Keratinocytes secretome was shown to
trigger the secretion of factors such as VEGF-A, FGFs,
Ang-1 and hepatocyte growth factor/scatter factor (HGF/
SF) by fibroblasts [53–55], known to induce EC migra-
tion, tubule formation and stabilization [56,57]. Addi-
tionally, a stiffer microenvironment formed by ECM
proteins deposited by fibroblasts correlates with
enhanced EC vessel sprouting with lumen formation
[58]. It is also known that the capacity ECM has to retain
specific molecules is also determinant for this fibroblasts-
ECs crosstalk [59]. This is the case of the ECM produced
by the papillary fibroblasts that supports the formation of
a robust array of highly branched tube-like structures due
to the capacity to link HGF/SF, known to be critical for
EC differentiation [60]. While this differentiated capacity
of fibroblasts to support ECs could be explored for
cutaneous wound healing, the use of pure papillary and
reticular fibroblasts is still dependent on the identification
of specific surface for their isolation [61]. There are also
other fibroblasts subpopulations that could be of interest
to explore in this context [61], therefore, the subsequent
elucidation of the role of each fibroblast subpopulation in
angiogenesis is pivotal for their use as alternative to target
vascularization.
Adipose tissue as a cell source
The adipose tissue constitutes a relevant source cells for
tissue repair and regeneration due to a wide range of
features [62]. The adipose-derived stem cell (ASCs), in
particular, are known to secrete various growth factors,
including VEGF-A, FGFs, transforming growth factor-b
(TGF-b), placental growth factor (PGF), and anti-apo-
ptotic factors [63–65], which have lead their exploitation
as key pro-angiogenic mediators. Increased neo-vascular-
ization due to the paracrine interaction of the ASCs with
host resident cells was in fact confirmed in full-thickness
excisional mice wounds [66]. Increased blood flow in a
third degree burn in sheep was also attributed to the
VEGF secreted by the transplanted ASCs [67]. Similarly,
the secretion of HSF by ASCs was also correlated with aCurrent Opinion in Biotechnology 2022, 73:253–262 significantly higher number of ECs in full-thickness mice
ulcers [68]. This effect can be however dependent on the
time of residence of the transplanted cells as shown by the
secreted VEGF, Ang-1 and bFGF dose-dependent num-
ber of vessels formed at early time-points in a deep partial
thickness burn in pigs [69]. This angiogenic effect of the
ASCs was further shown to synergize with platelet-rich
plasma (PRP) as revealed by the higher EPCs recruit-
ment and enhanced neovascularization attained in full-
thickness wounds in diabetic rats. This was due to an
upregulation of VEGF and SDF-1 when compared to
only ASCs and only PRP groups [70]. Interestingly, this
did not seem to happen with hyaluronic acid byproducts,
at least from 2 weeks after transplantation onward at
which the condition only with gellan gum/hyaluronic acid
showed higher vessel density than that when it was
combined with ASCs [30]. This is potentially due to a
residence time for the transplanted ASCs lower than
2 weeks.
Adipose tissue stromal vascular fraction (SVF) comprises,
in addition to ASCs, several other cell types including
fibroblasts, pre-adipocytes, ECs and hematopoietic cells
[71,72]. This cell complexity present in SVF allows
generating a dynamic and self-regulating angiogenic
microenvironment capable of promoting the neovascular-
ization of ischemic tissues [65]. A comparative study
involving ASCs and SVF injected in full-thickness wound
in diabetic mice, showed that the number of EC at the
wound site was superior in the SVF group [73]. Interest-
ingly, the angiogenic environment supported by SVF
cells also permits to attain in vitro complex and inter-
connected capillary-like networks in the absence of
extrinsic growth factors [74]. This allowed using SVF
cells to generate pre-vascularized dermo-epidermal con-
structs that inosculated with the host tissue after implan-
tation in a full-thickness rat model, forming abundant
perfused human/rat chimeric vessels [75]. Authors under-
line that SVF cell composition, specially the transplanted
ECs/EPCs (CD31+ cells) and the ASCs (CD90+ cells) are
responsible for the generation of mature and stable
capillaries [75]. Another study showed that the level of
maturation of the pre-vascular network formed from SVF
cells also influences the vascularization of full-thickness
rat wounds [76]. Faster inosculation and superior survival
of transplanted cells is linked to pericytes, whose number
was significantly higher in the more mature constructs
[76]. A full-scale randomized clinical trial for the treat-
ment of chronic wounds showed that pre-vascularized
dermal-epidermal skin constructs using the SVF-derived
endothelial cell population promote vascular network
regeneration. The preliminary results published so far
showed that the vascular beds of the hypodermis were
denser in the pre-vascularized group, which also depicted
faster wound closure [77]. These results positively sup-
port the use of SVF to enhance the vascularization of
cutaneous wounds, and additional knowledge regardingwww.sciencedirect.com
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take a greater number of approaches in the clinical
setting.
Conclusion and future perspectives
There is a pressing need to improve vascularization in
skin wound healing, as it is a crucial step to promote
better healing and improve neotissue quality. However, it
is also clear that strategies capable of triggering controlled
vascularization by vasculogenesis or angiogenesis are still
a challenge. Biomaterial-based and cell-based approaches
open up the possibility of engineering constructs that
allow regulating angiogenesis/vasculogenesis at different
levels. Biomaterial-based strategies were proven capable
of regulating localized vascularization during healing
through integrin-mediated responses to peptide-
functionalized biomaterials. However, its effectiveness
in cutaneous wounds is still to be demonstrated and the
fundamental understanding of those responses and the
engagement of those peptides as angiogenic/vasculogenic
initiators requires further investigation. Concomitantly,
the use of angiogenic biomaterials or the release/delivery
of angiogenic biomolecules or respective encoding
genetic material in the wound allow to achieve a temporal
effect on vascularization. While this is critical, those
approaches have shown limited control due to the low
dependence of the release/delivery profiles on the wound
environment, and in particular on wound features such as
pH and temperature. Therefore, the use of materials that
respond to those stimuli releasing a certain biomolecule,
for example, would allow responding to the specific needs
of each stage of wound healing or different type of
wounds. Additionally, given the temporal complexity of
the wound healing process, the combination of those
features with the spatial cell response mediated by integ-
rins is likely to be relevant not only in successfully
accelerating angiogenesis, critical to foster wound closure,
but also to mediate the transition from the inflammatory
to the proliferative phase of the healing, supporting the
formation of neotissue with a quality closer to the native
one. Nonetheless, new knowledge about the spatial and
temporal regulation of angiogenesis during the healing of
different types of wounds will also pave the way to further
advance biomaterials’ properties to improve
effectiveness.
Pre-vascularized cellular approaches are highly effective
in fostering inosculation with host tissue and conse-
quently enhancing neovascularization. However, the
availably of the ECs at clinically relevant numbers for
constructs pre-vascularization has been challenging to
attain. On the other side, current skin substitutes are
in general effective in promoting wound healing but can
be associated to delayed t neo-vascularization. Knowing
that the crosstalk between the epidermal cells, dermal
fibroblasts and ECs, favors angiogenesis associated
responses from ECs, skin substitutes might be furtherwww.sciencedirect.com advanced by taking advantage of this knowledge.
Advances in genetic engineering might be critical to
explore of those interactions by modifying fibroblasts
and/or keratinocytes to respond, as part of skin substi-
tutes, to a specific signaling or to secrete a molecule that
directly interacts with host ECs. Moreover, this vision in
combination with what was discussed from the biomate-
rial-based perspective, can also foster the development of
improved GAMs.
From the perspective of having cellular approaches with
low or none cell manipulation, adipose tissue must be
considered a highly relevant source of cells. It is well
demonstrated that the ASCs angiogenic secretome posi-
tively impacts the vascularization of cutaneous wounds.
What is still to be better understood is how this potential
can be maximized in different wounds. One might spec-
ulate that strategies that enhance ASCs residence time
and support this angiogenic phenotype such as for exam-
ple the use of integrin-specific biomaterials could be
considered. On the other hand, due to their composition,
SVF has allowed the development of pre-vascularized
constructs which generate a self-regulatory angiogenic
environment being therefore an extremely powerful
alternative for promoting vascularization in cutaneous
wounds. Notwithstanding, the associated mechanisms
of action should be further investigated, to unravel their
true role fostering the translation of these approaches to
the clinical setting.
Overall, there are a wide range of approaches that can
contribute in different ways to tackle cutaneous wound
healing vascularization. Yet, their clinical relevance will
be determined from the generated outputs and how
deeply they respond to the ultimate need that is to
promote the formation of good quality neotissue. From
the vascularization point of view, that goes beyond the
current analysis of the number of vessel and relies on the
maturity of the generated vasculature and more impor-
tantly on the extent of blood flow provided to the neo-
tissue to guarantee long term functionality of the skin.
Moreover, with the advance of the knowledge and tools
that were discussed above, it is critical that strategies are
thought having in consideration the type of wound and
consequently its microenvironment. Taking into play
what is known about the healing progression, those might
also require connection not only to different wounds but
also to the stage of healing.
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